IL-28B polymorphisms and treatment response in hepatitis C virus patients with persistently normal alanine aminotransferase

doi:10.4254/wjh.v5.i11.635

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 11

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4709)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

242

HTML

2408

Figures (1-1)

218

Tables (1-4)

230

Sum=3098

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

853

Download

758

Sum=1611

Nov 27, 2013 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Hepatol. Nov 27, 2013; 5(11): 635-641
Published online Nov 27, 2013. doi: 10.4254/wjh.v5.i11.635

Full Size Figure Download Figure

Figure 1 Sustained virologic response rates according to interleukin 28B single-nucleotide polymorphism rs8099917, and alanine aminotransferase levels. A: All hepatitis C virus (HCV)-infected patients; B: HCV genotype 1-infected patients. SVR: Sustained virologic response; PNALT: Persistent normal alanine aminotransferase; ALT: Alanine aminotransferase.

Citation: Miyamura T, Kanda T, Nakamura M, Jiang X, Wu S, Nakamoto S, Mikami S, Takada N, Imazeki F, Yokosuka O. IL-28B polymorphisms and treatment response in hepatitis C virus patients with persistently normal alanine aminotransferase. World J Hepatol 2013; 5(11): 635-641
URL: https://www.wjgnet.com/1948-5182/full/v5/i11/635.htm
DOI: https://dx.doi.org/10.4254/wjh.v5.i11.635